Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Nov 27, 2023 10:48am
145 Views
Post# 35754344

RE:RE:RE:RE:RE:My, my.....Ithno and Ionc working overtime to trash Oncy....

RE:RE:RE:RE:RE:My, my.....Ithno and Ionc working overtime to trash Oncy....Angler----my only take away from all of this is that the exec never really had very many shares to sell anyway so for CF to state that they have never sold a single share without telling the whole story that some never even had any shares was misleading to begin with IMO. And as someone else pointed out some shares had been sold a long time ago so CF"s statement was not factual where my statement showing the ownership by execs was taking from the AGM cirrcular.
Just curious, are you okay that managment has very little shares and thus very little risk and that they have tons of options and make great compensation and yet our sp is down about 80% from the consolidation, you can't really be ok with all of that, and on top of that everyone said that the precision trial was the best thing for the company and now that is gone. You really good with all that, Yes we have results but we need the follow up and to be in talks for years has not shown much in the way of shareholder value. Will it happen, I sure hope so but when is the question and so far it is only anticipation for mid 2024. They need to get a deal signed and that is all there is to it or a nice BO. That is the bottome line and I think we can all be in agreement on that.
<< Previous
Bullboard Posts
Next >>